The Sequenom case has finally been decided by the federal appeals court. The court struck down the patent for a Down Syndrome Test.
We first reported on the case back in January of 2013.
Our most recent update was in June of 2014.
You can read a detailed analysis of the decision on the PharmaPatents blog here.
We predict that the case will be appealed to the US Supreme Court and the SCOTUS will deny cert.
